At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6,788 enrolled
Drug / intervention
Tiotropium/Olodaterol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Early Intervention Effectiveness of Tiotropium / Olodaterol Compared to Tiotropium in COPD
In Brief
An observational study evaluating Tiotropium/Olodaterol and Tiotropium for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 6,788 participants across 1 site.
Detailed Summary
This study aims to evaluate the time to escalation to triple therapy among the Japanese Chronic obstructive pulmonary disease (COPD) patients newly initiating therapy with a combination of Olodaterol and Tiotropium (herein referred to as Tio/Olo) using real world data.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartMar 2020
Primary CompletionAug 2020
TodayJul 2026
First PostedJan 30, 2020
Enrollment StartMar 27, 2020
Primary CompletionAug 12, 2020
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.4 years ago
Interventions
Tiotropium/Olodateroldrug
Soft Mist Inhaler product
Tiotropiumdrug
Soft Mist Inhaler product